证券记录 · 已归档季度
ARQT
Arcutis Biotherapeutics, Inc. · Healthcare · Biotechnology
13被追踪持有人
+1Δ持有人
15.11M持有股份
$210.56M报告持仓市值
+1新建仓位
−0清仓
动量输入(同类管理人):
持有人广度 +8.3% ·
股份流向 +4.3% ·
净新建仓位 +7.7%
— 公式
广泛积累 — 持股数量上升且持有人增多
所有持股数据:仅限已追踪的 13F 管理人,普通股持仓,报告期 Q4 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 105 | +8 | 69.46M | $1.82B | +11 | −2 |
| Q1 2026 | 99 | +1 | 69.94M | $1.65B | +6 | −6 |
| Q4 2025 | 97 | +2 | 70.50M | $2.05B | +3 | — |
| Q3 2025 | 16 | 0 | 32.55M | $613.65M | +1 | −2 |
| Q2 2025 | 14 | -2 | 28.30M | $396.73M | — | −2 |
| Q1 2025 | 13 | 0 | 11.91M | $186.25M | +1 | −1 |
| Q4 2024 | 13 | +1 | 15.11M | $210.56M | +1 | — |
| Q3 2024 | 11 | +1 | 9.54M | $88.77M | +2 | −1 |
| Q2 2024 | 10 | — | 8.25M | $76.75M | — | — |
持有人 · Q4 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (被动) | 4.95M | — | $68.96M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | D. E. Shaw & Co. ✦ | 2.51M | +44.0% | $35.01M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 3 | D. E. Shaw & Co. ✦ | 2.51M | +44.0% | $35.01M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Geode Capital Management ✦ (被动) | 2.47M | +0.1% | $34.45M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Geode Capital Management ✦ (被动) | 2.47M | +0.1% | $34.45M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Millennium Management ✦ | 2.31M | +101.3% | $32.18M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | Point72 Asset Management ✦ | 1.75M | +617.5% | $24.43M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 8 | Norges Bank ✦ (被动) | 532.79K | +204.8% | $7.42M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 204.48K | -18.9% | $2.85M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 204.48K | -18.9% | $2.85M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 204.48K | -18.9% | $2.85M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 204.48K | -18.9% | $2.85M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 13 | Adage Capital Partners ✦ | 100.00K | 新增 | $1.39M | 0.0% | New | 1 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 89.17K | -97.1% | $1.24M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 15 | Citadel Advisors ✦ | 89.17K | -97.1% | $1.24M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | Two Sigma Investments ✦ | 84.84K | -51.1% | $1.18M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 17 | Wellington Management ✦ | 49.27K | -7.3% | $686,290 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | Wellington Management ✦ | 49.27K | -7.3% | $686,290 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | Wellington Management ✦ | 49.27K | -7.3% | $686,290 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 20 | Wellington Management ✦ | 49.27K | -7.3% | $686,290 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 21 | T. Rowe Price ✦ | 42.35K | -29.6% | $590,000 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 22 | Renaissance Technologies ✦ | 11.10K | -94.2% | $154,609 | 0.0% | ▼ Trim | 2 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Adage Capital Partners | $1.39M | 0.0% |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构(SEC结构化数据, Q1 2026): 267 持有人, 132.09M 股份, $3.07B 已申报. 这是与上方被追踪全域数据不同的较早期间,两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数,而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 20
Curran Terrie
Director · 1.07K 股 · $27,912
Aug 19
Burnett Patrick
Officer · 1.70K 股 · $45,819
Aug 17
Welgus Howard G.
Director · 4.73K 股 · $123,835
Aug 12
Burnett Patrick
Officer · 6.70K 股 · $174,767
Aug 11
Burnett Patrick
Officer · 8.30K 股 · $220,129
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 14
SC 13G — Polar Capital Holdings Plc
Aug 07
SC 13G — STATE STREET CORP
数据来源: 持股数据来源于已解析的13F普通股持仓(被追踪范围,变动对比集);内部人行为来自Form 3/4/5;重大持股来自Schedule 13D/13G;所有文件均链接至SEC EDGAR原始申报。
报告期: Q4 2024 ·
方法论 ·
通过API获取此数据